No image on file

Glenmark Pharmaceuticals Inc., USA

clindamycin and benzoyl peroxide

Targeted treatments · 35.0 g

Product form: Gel
Recorded market: United States
Ingredient list: 7 label entries
Ingredient research: 4 ingredients with selected studies

Explore the formula ↓Where to find it ↗

7 label entries · 4 linked ingredients

Explore connections

About this product

Product description

Clindamycin and Benzoyl Peroxide Gel, 1%/5% contains clindamycin phosphate, (7(S)-chloro-7-deoxylincomycin-2-phosphate). Clindamycin phosphate is a water soluble ester of the semi-synthetic antibiotic produced by a 7(S)-chloro-substitution of the 7(R)-hydroxyl group of the parent antibiotic lincomycin. Chemically, clindamycin phosphate is (C18H34ClN2O8PS). The structural formula for clindamycin is represented below: Clindamycin phosphate has a molecular weight of 504.96 g/mol and its chemical name is Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido) -1-thio-L-threo-α-D- galacto-octopyranoside 2-(dihydrogen phosphate). Clindamycin and Benzoyl Peroxide Gel, 1%/5% also contains benzoyl peroxide, for topical use. Chemically, benzoyl peroxide is (C14H10O4). It has the following structural formula: Benzoyl peroxide has a molecular weight of 242.23 g/mol. Each gram of Clindamycin and Benzoyl Peroxide Gel, 1%/5% contains, as dispensed, 10 mg (1%) clindamycin as phosphate and 50 mg (5%) benzoyl peroxide in a base of carbomer homopolymer type C, docusate sodium, edetate disodium, sodium hydroxide and purified water.

Description from DailyMed · Recorded Aug 9, 2026. Product claims have not been independently verified.

Label directions

Clindamycin and Benzoyl Peroxide Gel should be applied twice daily, morning and evening, or as directed by a physician, to affected areas after the skin is gently washed, rinsed with warm water and patted dry.

Directions from DailyMed.

From the recorded source

Regulatory label information

Label text from DailyMed · Recorded Aug 9, 2026. Read the current label on your own pack; instructions and formulations can differ by market.

Label uses

Clindamycin and Benzoyl Peroxide Gel is indicated for the topical treatment of acne vulgaris.

Warnings from the label

ORALLY AND PARENTERALLY ADMINISTERED CLINDAMYCIN HAS BEEN ASSOCIATED WITH SEVERE COLITIS WHICH MAY RESULT IN PATIENT DEATH. USE OF THE TOPICAL FORMULATION OF CLINDAMYCIN RESULTS IN ABSORPTION OF THE ANTIBIOTIC FROM THE SKIN SURFACE. DIARRHEA, BLOODY DIARRHEA, AND COLITIS (INCLUDING PSEUDOMEMBRANOUS COLITIS) HAVE BEEN REPORTED WITH THE USE OF TOPICAL AND SYSTEMIC CLINDAMYCIN. STUDIES INDICATE A TOXIN(S) PRODUCED BY CLOSTRIDIA IS ONE PRIMARY CAUSE OF ANTIBIOTIC-ASSOCIATED COLITIS. THE COLITIS IS USUALLY CHARACTERIZED BY SEVERE PERSISTENT DIARRHEA AND SEVERE ABDOMINAL CRAMPS AND MAY BE ASSOCIATED WITH THE PASSAGE OF BLOOD AND MUCUS. ENDOSCOPIC EXAMINATION MAY REVEAL PSEUDOMEMBRANOUS COLITIS. STOOL CULTURE FOR Clostridium Difficile AND STOOL ASSAY FOR C. difficile TOXIN MAY BE HELPFUL DIAGNOSTICALLY. WHEN SIGNIFICANT DIARRHEA OCCURS, THE DRUG SHOULD BE DISCONTINUED. LARGE BOWEL ENDOSCOPY SHOULD BE CONSIDERED TO ESTABLISH A DEFINITIVE DIAGNOSIS IN CASES OF SEVERE DIARRHEA. ANTIPERISTALTIC AGENTS SUCH AS OPIATES AND DIPHENOXYLATE WITH ATROPINE MAY PROLONG AND/OR WORSEN THE CONDITION. DIARRHEA, COLITIS, AND PSEUDOMEMBRANOUS COLITIS HAVE BEEN OBSERVED TO BEGIN UP TO SEVERAL WEEKS FOLLOWING CESSATION OF ORAL AND PARENTERAL THERAPY WITH CLINDAMYCIN. Mild cases of pseudomembranous colitis usually respond to drug discontinuation alone. In moderate to severe cases, consideration should be given to management with fluids and electrolytes, protein supplementation and treatment with an antibacterial drug clinically effective against C. difficile colitis.

Other label information

Store at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. Do not freeze. Keep tightly closed. Keep out of reach of children. Rx Only Distributed by: Glenmark Pharmaceuticals Inc., USA Elmwood Park, NJ 07407 Questions? 1 (888) 721-7115 www.glenmarkpharma-us.com July 2025

The product, unpacked

Formula

Listed in label order. Position does not establish an exact concentration. Ingredient roles describe possible uses and can vary with the finished formula.

Full recorded ingredient list

CLINDAMYCIN PHOSPHATE, BENZOYL PEROXIDE, DOCUSATE SODIUM, EDETATE DISODIUM, CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED), SODIUM HYDROXIDE, WATER

4 of 7 entries are linked to ingredient pages below. Unmatched names remain in the original list above.

Explore the ingredients

02
BENZOYL PEROXIDE ↗Antimicrobial · Oxidising
04
EDETATE DISODIUM ↗Chelating · Viscosity controlling
06
SODIUM HYDROXIDE ↗Buffering · Denaturant
07
WATER ↗Antiplaque · Skin conditioning · Solvent

Formula provenance

Regulatory source · united-states

Recorded Aug 9, 2026

Formula source ↗

Formulas can vary by market and change over time. Check the ingredient list on your own pack.

Follow the connections

Ingredient research

These studies concern ingredients listed or declared for this product. They do not establish that this exact formula reproduces a study result, dose or delivery method.

Where to find it

Check price, stock and delivery with the retailer. These links are not a live availability check.

No retailer link is recorded.